46 research outputs found
Poverty and livelihoods in rural South Africa: Investigating diversity and dynamics of livelihoods. Case studies in Limpopo
Food Security and Poverty,
Factors associated with repeat genital symptoms among sexually transmitted infection service attendees in South Africa, 2015 - 2016
Background. South African guidelines recommend a syndromic approach for the management of sexually transmitted infections (STIs), based on the presence of genital symptoms. However, the guidelines do not prescribe specific indications for microbiology testing for patients presenting with or without repeat genital symptoms.Objectives. To describe the prevalence of and factors associated with repeat genital symptoms among STI service attendees at primary care facilities.Methods. This was a cross-sectional study at 7 STI primary care facilities participating in the aetiological surveillance of STIs between January 2015 and December 2016. Demographic and clinical information and appropriate genital specimens were collected from participants presenting with vaginal discharge syndrome (VDS), male urethral syndrome (MUS) and/or genital ulcer syndrome (GUS). Repeat genital symptoms were defined as self-reported history of the same STI-related genital symptoms in the preceding 12 months. Multivariable logistic regression identified factors associated with repeat genital symptoms.Results. Of 1 822 eligible participants, 480 (30%) had repeat genital symptoms (25% and 75% in the preceding 3 months and 12 months, respectively). Of those with repeat genital symptoms, the median age was 28 (interquartile range (IQR) 24 - 32) years, and 54% were females. The most common aetiological agents among participants with VDS, MUS and GUS were bacterial vaginosis (n=132; 55%), Neisseria gonorrhoeae (n=172; 81%) and ulcers (n=67; 63%), respectively. One hundred and seven (20%) participants had no detectable common STI aetiology. In the multivariable analysis, repeat genital symptoms were associated with HIV co-infection (adjusted odds ratio (aOR) 1.43; 95% confidence interval (CI) 1.14 - 1.78), VDS diagnosis (aOR 1.39; 95% CI 1.10 - 1.76), self-reported condom use (aOR 1.56; 95% CI 1.20 - 2.03) and age 25 - 34 years (aOR 1.33; 95% CI 1.03 - 1.71).Conclusions. Our study found a high prevalence of repeat genital symptoms ‒ a significant proportion without STI aetiology. Identified factors of repeat genital symptoms highlight the need for improved integration of HIV and STI prevention and management. Further research is needed to determine the aetiology of repeat genital symptoms and the contribution of non-STI causes
Factors associated with repeat genital symptoms among sexually transmitted infection service attendees in South Africa, 2015-2016
BACKGROUND. South African guidelines recommend a syndromic approach for the management of sexually transmitted infections (STIs),
based on the presence of genital symptoms. However, the guidelines do not prescribe specific indications for microbiology testing for
patients presenting with or without repeat genital symptoms.
OBJECTIVES. To describe the prevalence of and factors associated with repeat genital symptoms among STI service attendees at primary
care facilities.
METHODS. This was a cross-sectional study at 7 STI primary care facilities participating in the aetiological surveillance of STIs between
January 2015 and December 2016. Demographic and clinical information and appropriate genital specimens were collected from
participants presenting with vaginal discharge syndrome (VDS), male urethral syndrome (MUS) and/or genital ulcer syndrome (GUS).
Repeat genital symptoms were defined as self-reported history of the same STI-related genital symptoms in the preceding 12 months.
Multivariable logistic regression identified factors associated with repeat genital symptoms.
RESULTS. Of 1 822 eligible participants, 480 (30%) had repeat genital symptoms (25% and 75% in the preceding 3 months and 12 months,
respectively). Of those with repeat genital symptoms, the median age was 28 (interquartile range (IQR) 24 - 32) years, and 54% were females.
The most common aetiological agents among participants with VDS, MUS and GUS were bacterial vaginosis (n=132; 55%), Neisseria
gonorrhoeae (n=172; 81%) and ulcers (n=67; 63%), respectively. One hundred and seven (20%) participants had no detectable common STI
aetiology. In the multivariable analysis, repeat genital symptoms were associated with HIV co-infection (adjusted odds ratio (aOR) 1.43;
95% confidence interval (CI) 1.14 - 1.78), VDS diagnosis (aOR 1.39; 95% CI 1.10 - 1.76), self-reported condom use (aOR 1.56; 95% CI 1.20 -
2.03) and age 25 - 34 years (aOR 1.33; 95% CI 1.03 - 1.71).
CONCLUSIONS. Our study found a high prevalence of repeat genital symptoms ‒ a significant proportion without STI aetiology. Identified
factors of repeat genital symptoms highlight the need for improved integration of HIV and STI prevention and management. Further
research is needed to determine the aetiology of repeat genital symptoms and the contribution of non-STI causes.The SA National Department of Health through a core surveillance funding grant to the National Institute for Communicable Diseases (NICD).http://www.samj.org.zaam2021School of Health Systems and Public Health (SHSPH
Rapid impact of effective treatment on transmission of multidrug-resistant tuberculosis
BACKGROUND: Effective treatment for drug-susceptible tuberculosis (TB) rapidly renders patients noninfectious,
long before conversion of sputum acid-fast smear or culture to negative. Multidrug-resistant TB
(MDR-TB) patients on treatment are currently assumed to remain infectious for months. While the resources
required for prolonged hospitalization are a barrier to the scale-up of MDR-TB treatment, the safety of
community treatment is clear.
OBJECTIVES : To estimate the impact of treatment on infectiousness among MDR-TB patients.
METHODS: A series of five human-to-guinea pig TB transmission studies was conducted to test various
interventions for infection control. Guinea pigs in adjacent chambers were exposed to exhaust air from a
hospital ward occupied by mostly sputum smear- and culture-positive MDR-TB patients. The guinea pigs then
underwent tuberculin skin testing for infection. Only the control groups of guinea pigs from each study (no
interventions used) provide the data for this analysis.
The number of guinea pigs infected in each study is reported and correlated with Mycobacterium tuberculosis
drug susceptibility relative to treatment.
RESULTS : Despite exposure to presumably infectious MDR-TB patients, infection percentages among guinea
pigs ranged from 1% to 77% in the five experiments conducted. In one experiment in which guinea pigs were
exposed to 27 MDR-TB patients newly started on effective treatment for 3 months, there was minimal
transmission. In four other experiments with greater transmission, guinea pigs had been exposed to patients
with unsuspected extensively drug-resistant tuberculosis who were not on effective treatment.
CONCLUSIONS : In this model, effective treatment appears to render MDR-TB patients rapidly noninfectious.
Further prospective studies on this subject are needed.NIOSH R01OH009050http://www.ingentaconnect.com/content/iuatld/ijtldhb201
Butorphanol with oxygen insufflation corrects etorphine-induced hypoxaemia in chemically immobilized white rhinoceros (Ceratotherium simum)
Barriers and enablers for implementation of digital-linked diagnostics models at point-of-care in South Africa : stakeholder engagement
AVAILABILITY OF DATA AND MATERIALS : All data analyzed in the study is available upon written request from the corresponding author.The integration of digital technologies holds significant promise in enhancing accessibility to disease diagnosis and treatment at point-of-care (POC) settings. Effective implementation of such interventions necessitates comprehensive stakeholder engagements. This study presents the outcomes of a workshop conducted with key stakeholders, aiming to discern barriers and enablers in implementing digital-connected POC diagnostic models in South Africa. The workshop, a component of the 2022 REASSURED Diagnostics symposium, employed the nominal group technique (NGT) and comprised two phases: Phase 1 focused on identifying barriers, while Phase 2 centered on enablers for the implementation of digital-linked POC diagnostic models. Stakeholders identified limited connectivity, restricted offline functionality, and challenges related to load shedding or rolling electricity blackouts as primary barriers. Conversely, ease of use, subsidies provided by the National Health Insurance, and 24-h assistance emerged as crucial enablers for the implementation of digital-linked POC diagnostic models. The NGT workshop proved to be an effective platform for elucidating key barriers and enablers in implementing digital-linked POC diagnostic models. Subsequent research endeavors should concentrate on identifying optimal strategies for implementing these advanced diagnostic models in underserved populations.The workshop in which the study was conducted was part of the 1st REASSURED Diagnostics Symposium which was funded by the US Embassy’s US Partnership initiative.https://bmchealthservres.biomedcentral.comhj2024Nuclear MedicineRadiologySchool of Health Systems and Public Health (SHSPH)Non
Decreased severity of disease during the first global Omicron variant COVID-19 outbreak in a large hospital in Tshwane, South Africa
INTRODUCTION : The coronavirus disease 2019 (COVID-19) first reported in Wuhan, China in December 2019 is a global pandemic that is threatening the health and wellbeing of people worldwide. To date there have been more than 274 million reported cases and 5.3 million deaths. The Omicron variant first documented in the City of Tshwane, Gauteng Province, South Africa on 9 November 2021 led to exponen- tial increases in cases and a sharp rise in hospital admissions. The clinical profile of patients admitted at a large hospital in Tshwane is compared with previous waves. METHODS : 466 hospital COVID-19 admissions since 14 November 2021 were compared to 3962 admis- sions since 4 May 2020, prior to the Omicron outbreak. Ninety-eight patient records at peak bed occu- pancy during the outbreak were reviewed for primary indication for admission, clinical severity, oxygen supplementation level, vaccination and prior COVID-19 infection. Provincial and city-wide daily cases and reported deaths, hospital admissions and excess deaths data were sourced from the National Institute for Communicable Diseases, the National Department of Health and the South African Medical Research Council. RESULTS : For the Omicron and previous waves, deaths and ICU admissions were 4.5% vs 21.3% (p < 0.0 0 0 01), and 1% vs 4.3% (p < 0.0 0 0 01) respectively; length of stay was 4.0 days vs 8.8 days; and mean age was 39 years vs 49,8 years. Admissions in the Omicron wave peaked and declined rapidly with peak bed occupancy at 51% of the highest previous peak during the Delta wave. Sixty two (63%) patients in COVID-19 wards had incidental COVID-19 following a positive SARS-CoV-2 PCR test . Only one third (36) had COVID-19 pneumonia, of which 72% had mild to moderate disease. The remaining 28% required high care or ICU admission. Fewer than half (45%) of patients in COVID-19 wards required oxygen supplementation compared to 99.5% in the first wave. The death rate in the face of an exponential increase in cases during the Omicron wave at the city and provincial levels shows a decoupling of cases and deaths compared to previous waves, corroborating the clinical findings of decreased severity of disease seen in patients admitted to the Steve Biko Academic Hospital. CONCLUSION : There was decreased severity of COVID-19 disease in the Omicron-driven fourth wave in the City of Tshwane, its first global epicentre.The South African Medical Research Council.http://www.elsevier.com/locate/ijidam2023Critical CareInternal MedicineObstetrics and GynaecologyPaediatrics and Child HealthSchool of Health Systems and Public Health (SHSPH
Effect of Maternal HIV-1 Status and Antiretroviral Drugs on Haematological Profiles of South African Infants in Early Life
Maternal HIV-1 status and antiretroviral drug exposure may influence the haematological profiles of infants. We recruited infants from 118 uninfected control women and from 483 HIV-1 infected women who received no antiretroviral drugs (n=28), or received single-dose Nevirapine (sdNVP) (n=424) or triple-drug combination therapy (n=31) to reduce HIV-1 transmission. Blood was drawn from infants within 24 hours of delivery or 6-12 weeks post-delivery and full blood counts performed using a fully automated AcT-5-diff haematology analyser and reference controls. Exposed uninfected (EU; no NVP) differed from control infants only in having lower basophil counts and percentages. In all infant groups, leukocyte profiles showed characteristic quantitative changes with age in the first 6 weeks of life. HIV-1 infected infants displayed by 6 weeks elevations in white blood cells, lymphocyte, monocyte and basophil counts, and monocyte and basophil percentages, when compared to EU infants. At birth EU NVP-treated infants exhibited elevated monocyte percentages and counts and basophil counts that did not persist at 6 weeks. Interestingly, EU newborns of mothers with high CD4 counts (> 500 cells/ÎĽl) that had taken sdNVP had significantly elevated white blood cell, monocyte and basophil counts when compared to newborn infants of mothers with similar CD4 counts that had not taken sdNVP; this was not evident in infants of mothers with CD4 counts <200 cells/ÎĽl. These previously undescribed features may affect immune response capability in early life and clinical consequences of such changes need to be further investigated
Poverty and livelihoods in rural South Africa: Investigating diversity and dynamics of livelihoods. Case studies in Limpopo
REASSURED diagnostics at point-of-care in sub-Saharan Africa: A scoping review.
Point-of-care (POC) diagnostics that meet the REASSURED criteria are essential in combating the rapid increase and severity of global health emergencies caused by infectious diseases. However, little is known about whether the REASSURED criteria are implemented in regions known to have a high burden of infectious diseases such as sub-Saharan Africa (SSA). This scoping review maps evidence of the use of REASSURED POC diagnostic tests in SSA. The scoping review was guided by the advanced methodological framework of Arksey and O'Malley, and Levac et al. We searched the following electronic databases for relevant literature: Scopus, Dimensions, ProQuest Central, Google Scholar, and EBSCOhost (MEDLINE, CINAHL, as well as AFRICA-WIDE). Two reviewers independently screened abstracts and full-text articles using the inclusion criteria as reference. We appraised the quality of the included studies using the mixed-method appraisal tool (MMAT) version 2018. We retrieved 138 publications, comprising 134 articles and four grey literature articles. Of these, only five articles were included following abstract and full-text screening. The five included studies were all conducted in SSA. The following themes emerged from the eligible articles: quality assurance on accuracy of REASSURED POC diagnostic tests, sustainability of REASSURED POC diagnostic tests, and local infrastructure capability for delivering REASSURED POC diagnostic tests to end users. All five articles had MMAT scores between 90% and 100%. In conclusion, our scoping review revealed limited published research on REASSURED diagnostics at POC in SSA. We recommend primary studies aimed at investigating the implementation of REASSURED POC diagnostic tests in SSA